Ann: Company Update, page-12

There was significant emphasis on 'partnerships' to support funding - it wasnt specific - but based on what we know (from the previous ANNs) its either Private or Government enterprise that will help bankroll larger developments with the options to support us to FY2024 when we expect much better revenue to roll in?

My bet as alluded to by others - the pilot plant will get an ANN on its own that we should see a significant grant from the government to get it going for AnteoX.

AnteoBind seems the marketting push, and global reach will see it used in partnerships and royalty models. Assuming the 'services' stream will be private company pays ADO for development of assays/Anteobind conjugations and then AnteoBind has a commerical agreement based on royalties once the product hits the market.

No more free lunches is what I took from today.